A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

CELL RESEARCH

INST BIOCHEMISTRY & CELL BIOLOGY

1. State Key Research Development Program of China [2016YFC1200300]
2. Young Thousand Talent Program
3. Bill & Mellinda Gates Foundation
4. Early Career Investigator Award from the Bayer Hemophilia Awards Program
5. National PKU Alliance
6. AAPS Foundation
7. National Institute of General Medical Sciences [1R35GM119679]
8. College of Pharmacy at The Ohio State University